‘A large group of medical doctors, psychiatrists and researchers are demanding that the American Psychiatric Association retract a shady study that relied upon industry influence to determine the effectiveness of an antidepressant that’s widely prescribed among children and teens.
The study, published more than a decade ago in the American Journal of Psychiatry, touted the benefits of Celexa in younger populations suffering from depression.
However, a recent analysis of the research found “gross misrepresentations” about the safety and effectiveness of the drug, including the fact that Celexa worked no better than the placebo.’
